This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Charlotte, NC-based Albemarle Corporation is a premier specialty chemicals company with leading positions in attractive end markets globally. It is a leading producer of highly-engineered specialty chemicals geared to meet customer requirements across a bevy of end markets including petroleum refining, consumer electronics, energy storage, construction and automotive.
Here's Why You Should Retain Albemarle (ALB) in Your Portfolio
by Zacks Equity Research
While Albemarle (ALB) faces headwinds from demand weakness in specialties, it benefits from higher lithium demand and actions to boost global lithium capacity.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Albemarle (ALB) Stock Moves 0.12%: What You Should Know
by Zacks Equity Research
In the latest trading session, Albemarle (ALB) closed at $184.58, marking a +0.12% move from the previous day.
Albemarle (ALB) Secures $90M Grant to Expand Lithium Production
by Zacks Equity Research
Albemarle (ALB) secures a $90 million grant from the U.S. Department of Defense to reopen the Kings Mountain lithium mine and commit to responsible mining practices.
Here's Why Albemarle (ALB) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Albemarle (ALB) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Albemarle (ALB) closed at $187.57, marking a -1.19% move from the previous day.
Is Trending Stock Albemarle Corporation (ALB) a Buy Now?
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Albemarle (ALB). This makes it worthwhile to examine what the stock has in store.
Albemarle (ALB) Makes Revised Offer for Liontown Resources
by Zacks Equity Research
Albemarle (ALB) makes a revised non-binding proposal to acquire Liontown Resources Limited for $4.3 billion.
Albemarle (ALB) Down 0.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Albemarle Corporation (ALB) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Albemarle (ALB) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Zacks Industry Outlook Highlights Air Products and Chemicals, DuPont de Nemours and Albemarle
by Zacks Equity Research
Air Products and Chemicals, DuPont de Nemours and Albemarle are part of the Zacks Industry Outlook article.
3 Diversified Chemical Stocks to Watch Amid Demand Woes
by Anindya Barman
Demand softness in certain markets, destocking and the slowdown in China and Europe pose headwinds for the Zacks Chemicals Diversified industry. APD, DD and ALB are poised to navigate the industry challenges.
Why Albemarle (ALB) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why You Should Hold Onto Albemarle (ALB) Stock for Now
by Zacks Equity Research
While Albemarle (ALB) faces headwinds from softness in specialties, it benefits from higher lithium volumes and actions to boost its global lithium capacity.
Algoma Steel's (ASTL) Q1 Earnings and Revenues Decline Y/Y
by Zacks Equity Research
Algoma Steel's (ASTL) fiscal first-quarter earnings and revenues fall year over year. EAF project progresses.
Best Value Stocks to Buy for August 9th
by Zacks Equity Research
ALB, CVGI and TTMI made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 9, 2023.
New Strong Buy Stocks for August 9th
by Zacks Equity Research
POST, ALB, SUM, WTS and CVGI have been added to the Zacks Rank #1 (Strong Buy) List on August 9, 2023.
Zacks.com featured highlights Alibaba, Encompass Health, Molson Coors, Ford Motor and Albemarle
by Zacks Equity Research
Alibaba, Encompass Health, Molson Coors, Ford Motor and Albemarle have been highlighted in this Screen of The Week article.
5 Lucrative Value Picks Based on Discounted PEG
by Urmimala Biswas
Here are five stocks that match our screening criteria, BABA, EHC, TAP, F and ALB.
Albemarle's (ALB) Q2 Earnings Top Estimates, Revenues Lag
by Zacks Equity Research
Higher prices from Energy Storage and Ketjen units drive Albemarle's (ALB) earnings in the second quarter.
Albemarle (ALB) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Albemarle (ALB) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Albemarle (ALB) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Albemarle (ALB) delivered earnings and revenue surprises of 71.66% and 5.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Why Albemarle (ALB) Might Surprise This Earnings Season
by Zacks Equity Research
Albemarle (ALB) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Air Products (APD) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Air Products (APD) is likely to have benefited from improved price and volumes and its productivity actions in the fiscal third quarter.
Albemarle (ALB) to Post Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Albemarle (ALB) is expected to have benefited from higher lithium volumes and its cost-reduction actions in Q2 amid headwinds from higher input costs and destocking.